Alpha Teknova, Inc. Common Stock

€3.431
EUR
Last updated on --.
24h volume193.79K
24h highest3.6120 EUR
24h lowest3.3454 EUR
24h Price movement+0.00%

TKNO recent prices

24 Hours
+0.00%€0.00
30 days
+24.74%+€0.69574
60 days
+52.20%+€1.203
90 days
+58.10%+€1.289

Key data

Previous close3.4314 EUR
Market cap170.60M EUR
Volume193.79K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.27520 EUR
Net income (FY)-14.77M EUR
Revenue (FY)35.95M EUR
Last report dateMay 7, 2026

About Alpha Teknova, Inc. Common Stock

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
HeadquartersHOLLISTER
Employees (FY)158.00
Revenue per employee (FY)227.53K EUR
Net income per employee (FY)-93.45K EUR
Listed onNasdaq
Official website

TKNO conversion tables

TKNOTKNO
EUREUR
0.5 TKNO1.715 EUR
1 TKNO3.431 EUR
5 TKNO17.15 EUR
10 TKNO34.31 EUR
EUREUR
TKNOTKNO
0.5 EUR0.14571 TKNO
1 EUR0.29143 TKNO
5 EUR1.457 TKNO
10 EUR2.914 TKNO

FAQ

TKNO is trading at €3.431, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TKNO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TKNO is currently trading at €3.431, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TKNO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TKNO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TKNO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TKNO's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Alpha Teknova, Inc. Common Stock's market cap is currently 170.60M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume193.79K
24h highest3.6120 EUR
24h lowest3.3454 EUR
24h Price movement+0.00%
TKNOTKNO
EUREUR
Start trade with TKNO Perpetual